NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/20/2025
Back to search
Official data from USPTO
HELSINN HELSINN ADVANCED SYNTHESIS WHERE PASSION, RELIABILITY AND QUALITY MEET
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
11/21/2025
Trademark type
Combined
Nice classes
5, 40, 42
Filing date
05/16/2019
Registration date
09/08/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/08/2020
Last transaction
11/21/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
33
Owner location
CH
Examiner
JOINER,KATINA JACKSON
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized letter "H" made out of four square-like shapes. The two shapes to the left in the letter are blue and light blue, with the light blue on the bottom. The two shapes to the right in the letter are both blue. To the right of the stylized letter is the term "HELSINN" also in a stylized font and in the color silver. Beneath this term is the wording "HELSINN ADVANCED SYNTHESIS" in a stylized font and the color light blue. Beneath this wording is "WHERE PASSION, RELIABILITY AND QUALITY MEET" in a stylized font and in the color blue.
Holders and representatives
Holders
Helsinn Healthcare SA
Representatives
Amanda Laura Nye Amanda Nye Law Offices
Technical classification
Nice Classes
Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
A full line of pharmaceuticals in the field of supportive cancer care; pharmaceutical preparationsanti-inflammatory drugsantiemetic drugsdrugs for the treatment of cancercarcinomaleukemialymphomamelanomaanti-tumor drugsanti-emeticanti-tumor and anticancer pharmaceutical preparations for the treatment of oncological diseases and the side effects of treatment; drugs for use in case of ulcerative and inflammatory conditionsanti-anxiety drugsanti-migraine drugscognition enhancing drugsdrugs for the prevention and treatment of gastroenterologicalhepatologicnephrologic and cardiovascular disorders of any origin; drugs for internal cleansing purposesbowel cleansers and evacuants for medical and pharmaceuticals purposesveterinary vaccines and sanitary preparations for medical use; dietetic foods adapted for medical usefood for babies; medical and surgical plastersmaterials for dressings in the nature of bandages; materials for stopping teethdental wax; disinfectants for sanitary and hygiene purposes; preparations for destroying vermin; fungicidesherbicides
Class 40
Custom manufacture of pharmaceutical products per customer order and in accordance with customer requirements
Class 42
Research and development of pharmaceutical products; scientific and industrial research for the development of medicines and active ingredients; chemistry servicesconsultancy in the field of chemical and pharmaceutical technology; engineering servicesincluding expertise in the field of chemical and pharmaceutical technology
Publications
History of USPTO decisions and trademark events.
33 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/08/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/19/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/15/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/28/2020
FIMP
FINAL DISPOSITION PROCESSED
12/28/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/08/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
09/08/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/23/2020
PUBO
PUBLISHED FOR OPPOSITION
06/23/2020
GPNX
NOTIFICATION PROCESSED BY IB
06/19/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/03/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/03/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/03/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/21/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/23/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/23/2020
ALIE
ASSIGNED TO LIE
04/22/2020
NREV
NOTICE OF REVIVAL - MAILED
04/18/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/17/2020
PETG
PETITION TO REVIVE-GRANTED
04/17/2020
PROA
TEAS PETITION TO REVIVE RECEIVED
04/17/2020
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
03/24/2020
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
03/23/2020
RFNT
REFUSAL PROCESSED BY IB
09/28/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/10/2019
RFRR
REFUSAL PROCESSED BY MPU
09/10/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/27/2019
CNRT
NON-FINAL ACTION WRITTEN
08/26/2019
MAFR
APPLICATION FILING RECEIPT MAILED
08/20/2019
DOCK
ASSIGNED TO EXAMINER
08/16/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/16/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/08/2019
Continuous trademark protection
Get notified about every new filing that threatens HELSINN HELSINN ADVANCED SYNTHESIS WHERE PASSION, RELIABILITY AND QUALITY MEET or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.